First patient treated in U.S.-approved embryonic stem cell trial
The first patient to be treated in a U.S.-government-approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells.
The patient, being cared for at the Shepherd Center in Atlanta, is partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.
According to the trial's protocol, patients must receive the stem cell injection within 14 days of the injury. The trial only involves patients with spinal cord injuries.
- Look Beyond Nurse-Patient Ratios
- Reform Puts Vise Grips on Physicians
- Medicare Opt-Out a Viable Physician Strategy
- Hospital Groups Back NQF Report on Patient Sociodemographics
- NPP Demand Rising Under Value-Based Care Models
- Providers Lag as Consumers Set Agenda
- Esther Dyson Launches Population Health Challenge
- Boston Marathon Bombing Yields Lessons for Hospitals
- The Flourishing Medical Tourism Business in America
- Physicians as Economic Powerhouses and Tech Laggards